Related Experiment Video
Updated: Jul 7, 2026
10:10
Transport Properties of Ibuprofen Encapsulated in Cyclodextrin Nanosponge Hydrogels: A Proton HR-MAS NMR Spectroscopy Study
Published on: August 15, 2016
Study of the interaction between hydroxymethylnitrofurazone and 2-hydroxypropyl-beta-cyclodextrin
Renato Grillo1, Nathalie F S de Melo, Carolina Morales Moraes
1Universidade Estadual Paulista Júlio de Mesquita Filho, Campus Sorocaba, Sorocaba, São Paulo, Brazil.
Journal of Pharmaceutical and Biomedical Analysis
|February 22, 2008
Summary
This study characterizes a new inclusion complex of Hidroxymethylnitrofurazone (NFOH) with 2-hydroxypropyl-beta-cyclodextrin (HP-beta-CD). The complex improves NFOH solubility, reduces toxicity, and enhances photostability, offering a promising approach for Chagas disease treatment.
Area of Science:
- Pharmaceutical Chemistry
- Medicinal Chemistry
- Drug Delivery Systems
Background:
- Chagas disease poses a significant health threat in Latin America.
- Hidroxymethylnitrofurazone (NFOH) is an active prodrug against Trypanosoma cruzi but suffers from poor solubility, photodecomposition, and toxicity.
- Developing stable and effective drug formulations is crucial for treating neglected tropical diseases.
Purpose of the Study:
- To characterize the inclusion complex of NFOH with 2-hydroxypropyl-beta-cyclodextrin (HP-beta-CD).
- To evaluate the impact of complexation on NFOH's solubility, stability, and toxicity.
- To explore a novel drug delivery strategy for improving NFOH efficacy.
Main Methods:
- Reversed-phase high-performance liquid chromatography (HPLC) with HP-beta-CD as a mobile phase additive.
- Solubility isotherm studies to determine complex stability constants.
- Nuclear magnetic resonance (NMR) spectroscopy for mobility and complexation analysis.
- Photostability assessments and preliminary cell viability tests.
Main Results:
- HPLC and solubility studies yielded apparent stability constants (K=6.2±0.3 M⁻¹ and K=7.9±0.2 M⁻¹, respectively) for the NFOH:HP-beta-CD complex.
- A 1:1 stoichiometry of the inclusion complex was indicated by the continuous variation method.
- The inclusion complex demonstrated enhanced photostability compared to free NFOH.
- Preliminary toxicity tests showed a significant reduction in NFOH-induced toxicity upon complexation (p<0.01).
Conclusions:
- Complexation with HP-beta-CD effectively improves the physicochemical properties of NFOH.
- The NFOH:HP-beta-CD inclusion complex offers a potential strategy to enhance the therapeutic efficacy and safety of NFOH for Chagas disease.
- Further investigation into this formulation is warranted for clinical development.
Related Concept Videos
01:14Drug Metabolism: Phase II Reactions
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
01:24Phase II Reactions: Glucuronidation
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
02:30Stability of Substituted Cyclohexanes
This lesson discusses the stability of substituted cyclohexanes with a focus on energies of various conformers and the effect of 1,3-diaxial interactions.
The two chair conformations of cyclohexanes undergo rapid interconversion at room temperature. Both forms have identical energies and stabilities, each comprising equal amounts of the equilibrium mixture. Replacing a hydrogen atom with a functional group makes the two conformations energetically non-equivalent.
For example, in...
The two chair conformations of cyclohexanes undergo rapid interconversion at room temperature. Both forms have identical energies and stabilities, each comprising equal amounts of the equilibrium mixture. Replacing a hydrogen atom with a functional group makes the two conformations energetically non-equivalent.
For example, in...
01:23Factors Affecting Dissolution: Particle Size and Effective Surface Area
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are employed to...
01:17Hepatic Drug Excretion: Enterohepatic Cycling
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...